HER2-Low expression in primary male breast cancer

被引：0
|
作者：
Rudlowski, Christian [1 ]
Erices-Leclercq, Melanie [1 ]
Nobbe, Katleen [1 ]
Baldus, Stephan [2 ]
Foerster, Robert [3 ]
Foerster, Frank [4 ]
Lubig, Sabine [1 ]
机构：
[1] EVK, Bergisch Gladbach, Germany
[2] Inst Pathol & Zytopathol, Bergisch Gladbach, Germany
[3] Cantonal Hosp Winterthur, Inst Radiat Oncol, Winterthur, Switzerland
[4] Poliklinik GmbH, MVZ Gynakol Onkol & Palliat Med, Chemnitz, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2024年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
96
引用
收藏
页码：29 / 29
页数：1
相关论文
共 50 条
  • [41] HER2-low breast cancer: A new clinical entity
    Rashid, Yasmin Abdul
    Khan, Samra
    Khan, Shagufta
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2025, 75 (01) : 149 - 150
  • [42] HER2-Low Breast Cancer: Molecular Characteristics and Prognosis
    Agostinetto, Elisa
    Rediti, Mattia
    Fimereli, Danai
    Debien, Veronique
    Piccart, Martine
    Aftimos, Philippe
    Sotiriou, Christos
    de Azambuja, Evandro
    CANCERS, 2021, 13 (11)
  • [43] Genomic and transcriptomic landscape of HER2-low breast cancer
    Bansal, Rani
    Adeyelu, Tolulope
    Elliott, Andrew
    Walker, Phillip
    Bustos, Matias A.
    Rodriguez, Estelamari
    Accordino, Melissa K.
    Meisel, Jane
    Gatti-Mays, Margaret E.
    Hsu, Emily
    Lathrop, Kate
    Kaklamani, Virginia
    Oberley, Matthew
    Sledge, George
    Sammons, Sarah L.
    Graff, Stephanie L.
    BREAST CANCER RESEARCH AND TREATMENT, 2025, 209 (02) : 323 - 330
  • [44] Insights Into the Emerging Entity of HER2-Low Breast Cancer
    El Haddad, Georges
    Diab, Ernest
    Hajjar, Michel
    Aoun, Maroun
    Mallat, Farid
    Zalaquett, Ziad
    Kourie, Hampig-Raphael
    INTERNATIONAL JOURNAL OF BREAST CANCER, 2024, 2024
  • [45] Improving HER2 testing reproducibility in HER2-low breast cancer
    Sajjadi, Elham
    Venetis, Konstantinos
    Ivanova, Mariia
    Fusco, Nicola
    CANCER DRUG RESISTANCE, 2022, 5 (04) : 882 - 888
  • [46] The frequency of low HER2 expression in breast cancer and a comparison of prognosis between patients with HER2-low and HER2-negative breast cancer by HR status
    Horisawa, Nanae
    Adachi, Yayoi
    Takatsuka, Daiki
    Nozawa, Kazuki
    Endo, Yuka
    Ozaki, Yuri
    Sugino, Kayoko
    Kataoka, Ayumi
    Kotani, Haruru
    Yoshimura, Akiyo
    Hattori, Masaya
    Sawaki, Masataka
    Iwata, Hiroji
    BREAST CANCER, 2022, 29 (02) : 234 - 241
  • [47] HER2-Low Breast Cancer Can Be Visualized by HER2 PET
    Altena, Renske
    af Buren, Siri
    Tran, Thuy
    Axelsson, Rimma
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64 (11) : 1842 - 1842
  • [48] Genomic Characterization of Primary and Metastatic HER2-low Breast Cancers
    Marra, Antonio
    Safonov, Anton
    Drago, Joshua
    Ferraro, Emanuela
    Selenica, Pier
    Gazzo, Andrea
    Curigliano, Giuseppe
    Modi, Shanu
    Razavi, Pedram
    Reis-Filho, Jorge
    Chandarlapaty, Sarat
    CANCER RESEARCH, 2023, 83 (05)
  • [49] The frequency of low HER2 expression in breast cancer and a comparison of prognosis between patients with HER2-low and HER2-negative breast cancer by HR status
    Nanae Horisawa
    Yayoi Adachi
    Daiki Takatsuka
    Kazuki Nozawa
    Yuka Endo
    Yuri Ozaki
    Kayoko Sugino
    Ayumi Kataoka
    Haruru Kotani
    Akiyo Yoshimura
    Masaya Hattori
    Masataka Sawaki
    Hiroji Iwata
    Breast Cancer, 2022, 29 : 234 - 241
  • [50] HER2-Low and Ultra-Low expression in young women with luminal breast cancer in Mexico
    Hernandez, Jesus Edgardo Hernandez
    Torres, Cesar Octavio Lara
    Moran, Bryan Moreno
    Garza, Cynthia Villareal
    Reyes, Fany Iris Porras
    Sanchez, Victor Manuel Perez
    Mohar, Alejandro
    CANCER RESEARCH, 2024, 84 (09)
12345